SCHEMBL7313265

SCHEMBL7313265

COC(=O)c1cc2ccc(C=O)cc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.54
▸ ALDH1A1 P00352 6/20 0.47
▸ HPGD P15428 4/20 0.46
▸ HDAC3 O15379 3/20 0.44
▸ HDAC4 P56524 3/20 0.44
▸ HDAC7 Q8WUI4 3/20 0.44
▸ HDAC2 Q92769 3/20 0.44
▸ HDAC10 Q969S8 3/20 0.44
▸ HDAC11 Q96DB2 3/20 0.44
▸ HDAC8 Q9BY41 3/20 0.44
▸ HDAC6 Q9UBN7 3/20 0.44
▸ HDAC9 Q9UKV0 3/20 0.44
▸ HDAC5 Q9UQL6 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PTPN2 P17706 1/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP2A6 P11509 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23480418 0.89 HDAC1 (0.55) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL9431827 0.88 MAPT (0.50) HDAC1ALDH1A1HPGDMAPTKDM4E
SCHEMBL34471063 0.87 HDAC1 (0.52) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL15697554 0.87 HDAC1 (0.52) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL1888306 0.84 PTPN2 (0.47) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL4394545 0.84 BCL2L1 (0.56) HDAC1ALDH1A1HDAC3HDAC4HDAC7
SCHEMBL13036388 0.83 DYRK1A (0.50) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL2250510 0.80 HDAC1 (0.69) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL31207866 0.80 HDAC1 (0.69) HDAC1ALDH1A1HPGDHDAC3HDAC4
SCHEMBL1886145 0.80 HDAC1 (0.80) HDAC1ALDH1A1HPGDHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207701-B1 AS ANTI-ANGIOGENIC, ANTI-ARTHRITIC, ANTI-INFLAMMATORY, ANTI-RETINOPATHIC, CONTRACEPTIVE AND TUMORISTATIC AGENTS ABBOTT LABORATORIES 2001-03-27 — — US disclosed
Send feedback